Report Library
View More
2025 American Academy of Neurology ...
May 22, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
2025 American Academy of Dermatolog...
June 3, 2025
2025 Biomedtracker Datamonitor Heal...
June 1, 2025
Datamonitor Healthcare Oncology: NH...
May 30, 2025
Datamonitor Healthcare Oncology: My...
May 29, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
Datamonitor Healthcare Oncology: Ho...
May 27, 2025
Datamonitor Healthcare Other: Uteri...
May 27, 2025
2025 Biomedtracker Datamonitor Hea...
May 23, 2025
2025 American Academy of Neurology ...
May 22, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
2025 American Academy of Dermatolog...
June 3, 2025
2025 Biomedtracker Datamonitor Heal...
June 1, 2025
Datamonitor Healthcare Oncology: NH...
May 30, 2025
Datamonitor Healthcare Oncology: My...
May 29, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
Datamonitor Healthcare Oncology: Ho...
May 27, 2025
Datamonitor Healthcare Other: Uteri...
May 27, 2025
2025 Biomedtracker Datamonitor Hea...
May 23, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/3/25 | GSK (GSK) | Zejula for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Johnson & Johnson (JNJ) | Akeega for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Pfizer (PFE) | Braftovi for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Bristol (BMY) | Opdualag IV for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Pfizer (PFE) | Mektovi for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
| 04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/12/2025 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 05/20/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/22/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |